Keyphrases
Pathophysiology
100%
MicroRNA
100%
Pancreatic Cancer
100%
Pancreatic Ductal Adenocarcinoma
100%
Translational Potential
100%
Am(III)
33%
Poor Prognosis
33%
Median Survival
33%
Tumor Suppressor
33%
Genetic Modification
33%
Tumor Growth
33%
5-year Survival
33%
Effective Therapy
33%
Human Cancer
33%
KRAS mutation
33%
Cancer Causes
33%
Cancer Mortality
33%
Tumor Protein p53 (TP53)
33%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
33%
Treatment Failure
33%
Diagnostic Tool
33%
Non-specific Symptoms
33%
Tumor Microenvironment
33%
Advanced Stage
33%
SMAD4
33%
Early Diagnostics
33%
Intrinsic Resistance
33%
Biochemistry, Genetics and Molecular Biology
Tumor Suppressor Protein
100%
Gene Mutation
100%
Survival Rate
100%
Tumor Progression
100%
Cancer Mortality
100%
KRAS
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Medicine and Dentistry
Pathophysiology
100%
Pancreas Adenocarcinoma
100%
Pancreas Cancer
100%
microRNA
100%
Cancer
33%
Tumor Progression
33%
Tumor Suppressor Protein
33%
Survival Rate
33%
Gene Mutation
33%
Cancer Mortality
33%
Stroma
33%
Cyclin Dependent Kinase Inhibitor 2A
33%
Tumor Microenvironment
33%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Pancreas Adenocarcinoma
100%
microRNA
100%
Pathophysiology
100%
Tumor Growth
33%
Tumor Suppressor Protein
33%
Survival Rate
33%
Cancer Mortality
33%
Tumor Microenvironment
33%
Intrinsic Resistance
33%
Cyclin Dependent Kinase Inhibitor 2A
33%